2016 Scientific Report
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
NING WU, PH.D.<br />
Dr. Wu received her Ph.D. from the Department of Biochemistry<br />
of the University of Toronto in 2002. She joined VARI in 2013 as<br />
an Assistant Professor.<br />
STAFF<br />
HOLLY DYKSTRA, B.S.<br />
ALTHEA WALDHART, B.S.<br />
STUDENT<br />
MATT HOLLOWELL<br />
RESEARCH INTERESTS<br />
Our laboratory studies the interface between cellular metabolism and signal<br />
transduction. The generation of two daughter cells depends on the proper uptake<br />
and use of nutrients that are often limited in the tumor environment. The distribution<br />
of these nutrients is controlled not only by the intrinsic catalytic rate and allosteric<br />
regulation of the enzymes, but also by post-translational modifications of these<br />
enzymes by signaling molecules. At the same time, signaling molecules must respond<br />
to cellular nutrient status and other cues such as environmental stresses and growth<br />
factors. Our laboratory focuses on key metabolic steps in glucose and lipid catabolism<br />
and aims to understand the mutual interactions between metabolites and signaling<br />
during cell replication.<br />
Fundamentally, cancer is a disease of uncontrolled cell growth. Relative to normal cells,<br />
tumor cells have aberrant metabolic addictions that differ depending on the cell’s tissue<br />
of origin and genetic mutations. By understanding the energy requirements and<br />
regulatory pathways of tumor cells, more-effective treatments can be developed. Our<br />
projects include unraveling the molecular mechanisms that regulate glucose uptake in<br />
cancers, investigating the effect of glucose on mitochondrial activity, and exploring the<br />
role of glucose as the link between metabolic syndrome and cancer incidence.<br />
26 Van Andel Research Institute | <strong>Scientific</strong> <strong>Report</strong>